Biofrontera (BFRIW) Return on Invested Capital (2021 - 2025)

Biofrontera's Return on Invested Capital history runs 5 years deep, the most recent figure standing at 0.03% for Q4 2025.

• In Q4 2025, Return on Invested Capital rose 1.0% year-over-year to 0.03%; the TTM figure through Dec 2025 stood at 0.03% (up 1.0% YoY), while the FY2025 annual figure was 0.02%, up 1.0% from the prior year.
• Return on Invested Capital was 0.03% for Q4 2025 at Biofrontera, down from 0.05% in the prior quarter.
• In the past five years, Return on Invested Capital ranged from a high of 0.18% in Q4 2021 to a low of 0.21% in Q2 2021.
• Historically, Return on Invested Capital has averaged 0.02% across 5 years, with a median of 0.02% in 2022.
• Biggest YoY gain for Return on Invested Capital was 20 bps in 2022; the steepest drop was 19 bps in 2022.
• A 5-year view of Return on Invested Capital shows it stood at 0.18% in 2021, then tumbled by 104 bps to 0.01% in 2022, then sank by 289 bps to 0.03% in 2023, then dropped by 29 bps to 0.03% in 2024, then climbed by 17 bps to 0.03% in 2025.
• The last three Return on Invested Capital figures came in at 0.03% (Q4 2025), 0.05% (Q3 2025), and 0.08% (Q2 2025), per Business Quant data.